Drawing for PODRAS

USPTO serial 86395195

PODRAS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
EULIN, INGRID C
Law office
TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PODRAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitisACTIVE—
042Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 13, 2017MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 13, 2017ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 9, 2016UNDCUNDELIVERABLE MAIL - COURTESY COPY MAILED—
Dec 5, 2016GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Dec 5, 2016GNSIINQUIRY TO SUSPENSION E-MAILED—
Dec 5, 2016CNSISUSPENSION INQUIRY WRITTEN—
Nov 14, 2016RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 10, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 10, 2016GNSLLETTER OF SUSPENSION E-MAILED—
May 10, 2016CNSLSUSPENSION LETTER WRITTEN—
Apr 16, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 16, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 13, 2016ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 7, 2016GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Feb 7, 2016GNSIINQUIRY TO SUSPENSION E-MAILED—
Feb 7, 2016CNSISUSPENSION INQUIRY WRITTEN—
Jan 8, 2016RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 8, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 8, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Jul 8, 2015CNSLSUSPENSION LETTER WRITTEN—
Jun 9, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 29, 2015ALIEASSIGNED TO LIE—
May 22, 2015ALIEASSIGNED TO LIE—
May 21, 2015NREVNOTICE OF REVIVAL - E-MAILED—
May 20, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 20, 2015PETGPETITION TO REVIVE-GRANTED—
May 20, 2015PROATEAS PETITION TO REVIVE RECEIVED—
Nov 4, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2014DOCKASSIGNED TO EXAMINER—
Sep 22, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 18, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance